News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NanoBio Corporation Announces Publication of Study Results For Intranasal Nanoemulsion-Adjuvanted Vaccine



7/21/2011 7:18:15 AM

ANN ARBOR, Mich.--(BUSINESS WIRE)--NanoBio® Corporation announced today that data from its ferret influenza vaccine study of NB-1008 have been published in the July 2011 issue of Clinical Vaccine Immunology by the American Society of Microbiology. Data generated from the study demonstrate the robust antigen-sparing properties of NB-1008 and provided the necessary validation to move immediately into human studies. A Phase 1a study of NB-1008 was subsequently completed in 2010, showing NB-1008 was well-tolerated while inducing both mucosal and systemic immunity following intranasal vaccination.

Read at BioSpace.com

Related News

comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES